NTLA and CRSP Related Headlines
Go Back- Intellia short interest rises most among biotech stocks in latest period - Baird
- Cutting DNA, Cutting Edge: Companies Using CRISPR and Other Gene Editing Technologies to Rewrite the Future of Industry and Medicine
- FDA Clears Way for Faster Personalized Gene Editing Treatments
- Intellia stock tumbles after pausing gene therapy trials on safety concerns
- Sam Altman Brain Chip Venture Is Mulling Gene Therapy Approach - Bloomberg
